Helene S. Negaard

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Deterioration in Physical Fitness and Changes in Body Composition After Cisplatin-Based Chemotherapy for Metastatic Testicular Cancer.

Deterioration in Physical Fitness and Changes in Body Composition After Cisplatin-Based Chemotherapy for Metastatic Testicular Cancer.

Journal: Clinical genitourinary cancer
Published: November 16, 2025

High-dose chemotherapy in male germ cell cancer patients-a study by the SWENOTECA group.

High-dose chemotherapy in male germ cell cancer patients-a study by the SWENOTECA group.

Journal: British journal of cancer
Published: September 12, 2025

Biochemical Hypogonadism in Aging Testicular Cancer Survivors: A Clinical Challenge.

Biochemical Hypogonadism in Aging Testicular Cancer Survivors: A Clinical Challenge.

Journal: European urology open science
Published: December 14, 2024

Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group Experience.

Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group Experience.

Journal: European urology open science
Published: May 31, 2024

Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium.

Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium.

Journal: European journal of cancer (Oxford, England : 1990)
Published: February 07, 2024

Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours.

Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours.

Journal: BJU international
Published: January 31, 2024

Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients.

Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients.

Journal: BJU international
Published: May 02, 2023

Association of physical activity with overall mortality among long-term testicular cancer survivors: A longitudinal study.

Association of physical activity with overall mortality among long-term testicular cancer survivors: A longitudinal study.

Journal: International journal of cancer
Published: February 08, 2023

Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort.

Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 13, 2021

Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium.

Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 06, 2021

Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.

Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 17, 2021

Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study.

Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 28, 2020
Showing 1-12 of 17

Last Updated: 09/26/2026